RESEARCH ATLASRESEARCH > HYPE
PUBLIC RESEARCH EDITION
Metabolic / appetite

Mazdutide

Mechanism not verified by source image · Peptide

Evidence at a glance

Each record keeps its own evidence class. Counts are records in this public edition, not a quality score.

Open in the interactive library →Compare with other compounds →

Records (1)

H

Human clinical / research

Human clinical / research

Mazdutide GLORY-1 trial

Administration reported for this specific study or labeled indication.

Context: Chinese adults with obesity or qualifying overweight

Human study regimen: Amount: 4 or 6 mg target arms; Route: Subcutaneous; Frequency: Once weekly; Duration: 48 weeks; Species: Human; Population: Chinese adults with obesity or qualifying overweight

Limitations: Randomized trial with a placebo comparator and China-specific BMI eligibility.

Route: Subcutaneous

Open this exact record in the library →Suggest a correction
CONTINUE THE RESEARCH

Follow the pathway.

These compounds share an Atlas pathway label. That is a navigation connection, not evidence of equivalent effects or suitability together.

5-Amino-1MQ7 labeled records →AOD-96043 labeled records →Adipotide1 labeled records →Cagrilintide3 labeled records →Eloralintide2 labeled records →O304 / ATX-304 research4 labeled records →
Browse this pathway in the library →

Educational research summary. Study amounts are research context, not a dose recommendation. Not medical advice.